Skip to main content
. 2021 Sep 11;71:103558. doi: 10.1016/j.ebiom.2021.103558

Fig. 4.

Fig 4

The clinical relevance of ZNF711 and SLC31A1 in EOC tissues. (a-b) The mRNA (a) and protein (b) expression of SLC31A1 in indicated cells with different expression levels of ZNF711. *p < 0.05 (one-way ANOVA with Bonferroni's correction). (c-d) SLC31A1 mRNA and protein expression in the indicated xenograft tumors. *p < 0.05 (one-way ANOVA with Bonferroni's correction). (e) Analysis of expression (left) and correlation (right) of mRNA and protein expression level of ZNF711 and SLC31A1 in 10 freshly collected EOC samples. (f) Representative image of ZNF711 and SLC31A1 expression in EOC tissues. Scale bars, 50 μm. (g) KM-plotter analysis was conducted to confirm the negative relation between SLC31A1 expression and survival of EOC patients treated with platin. Each bar shown in the figure represents the mean ± SD of three independent experiments.